PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsmyelodysplastic syndromes
MeSH D009190 - myelodysplastic syndromes
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001855:Bone marrow diseases
17 Companies
1 Drug
$
Success rate
D009190: 
Myelodysplastic syndromes
36 Companies
6 Drugs
$
Success rate
D000077428:Gata2 deficiency
0 Companies
0 Drugs
Success rate
D000753:Refractory anemia
18 Companies
1 Drug
$
Success rate
D000756:Sideroblastic anemia
18 Companies
1 Drug
$
Success rate
D006457:Paroxysmal hemoglobinuria
4 Companies
3 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Novast LaboratoriesDecitabine Decitabine  2019-09-16   
MylanAzacitidine Azacitidine Mylan  2020-03-27   
Lenalidomide Lenalidomide  2022-08-30   
Lenalidomide Lenalidomide Mylan  2020-12-18   
Johnson & JohnsonDecitabine Dacogen  2012-09-20   
CiplaDecitabine Decitabine  2017-11-16   
Lenalidomide Lenalidomide  2022-09-06   
Lupin ResearchDecitabine Decitabine  2018-11-09   
Lenalidomide Lenalidomide  2025-09-16   
SandozDecitabine Decitabine  2014-08-28   
Dr Reddys LaboratoriesDecitabine Decitabine  2013-07-11   
Lenalidomide Lenalidomide  2021-10-14   
Zydus TherapeuticsDecitabine Decitabine  2021-11-19   
Lenalidomide Lenalidomide  2022-09-12   
Sun Pharmaceutical IndustriesDecitabine Decitabine  2014-01-28   
Lenalidomide Lenalidomide  2023-02-08   
ApotexLenalidomide Lenalidomide  2022-08-30   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
75%
187/248
Phase 2
35%
90/255
Phase 3
21%
26/122
Approved: 5Overall Success rate: 6%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Johnson & Johnson
Decitabine,
Caficrestat,
Tipifarnib,
Doconexent,
Aspartame,
Bevifimod,
CUSATUZUMAB,
ONAMETOSTAT,
QUISINOSTAT,
Talacotuzumab,
Globulin, immune,
Krestin
Bristol Myers Squibb
Lenalidomide,
Azacitidine,
Luspatercept,
Calcium dobesilate,
Lornoxicam,
Aspartame,
Bevifimod,
LIRILUMAB,
Globulin, immune,
Krestin,
Anthracycline,
Aminoglycoside,
Darbeopoetin,
Solumedrol,
Cc5013
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use